Navigation Links
Ron Peele Named President of STB Lifesaving Technologies(R)
Date:2/2/2010

ROCKVILLE, Md., Feb. 2 /PRNewswire/ -- STB Lifesaving Technologies® announced today the hiring of Ron Peele as President, to lead its transition from an R&D stage initiative, to a commercial business.  Mr. Peele has spent the past 25 years building companies as both an investor and operating executive.  He joins STB® from Revolution Health, where he was a founding investor and CFO, working closely with Steve Case from its inception to merger with Everyday Health, where it's now the largest online health company.  Prior to that, Mr. Peele helped launch and build the AOL/Time Warner venture capital group, making strategic investments in some of the industry's most successful start-up companies.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100202/NE48377 )

STB®, which stands for "stop the bleeding," is developing a suite of products to control serious and life-threatening hemorrhage. Successful animal studies with both military and commercial partners, and published data from the American Red Cross, have demonstrated STB®'s flagship product, the Fibrin Adhesive STat or FAST® dressing, to be functionally superior.

"At the core of STB® is our collective mission to prevent deaths from bleeding, and the latest data on our flagship product is compelling and promising," said Peele.  "I've helped build many companies over the years, but this is my first opportunity to build something that can actually save people's lives.

"I had been working in an advisory role with founding investors Richard Moscarello and Jody Bellar, and the inventor of the technology, Dr. Martin MacPhee. During that time together we realized we all share the same vision for STB®.  Now Martin and his team of scientists can focus exclusively on the clinical and product development, while we focus on building strategic relationships and expanding resources to enable us to bring this product to patients who need it."

About STB®

Founded in 2005, STB Lifesaving Technologies® (STB®) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland.  STB® is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural protein technology with five patents and one provisional patent pending, STB®'s products will be indispensable to both the military and civilian medical markets.

SOURCE STB Lifesaving Technologies


'/>"/>
SOURCE STB Lifesaving Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aurora Hospitals Named Among the Nations Best
2. Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company
3. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
4. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
5. Biovista Inc. Named Top Innovator in Life Sciences
6. Fujirebio Diagnostics Named Life Sciences Company of the Year
7. Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation
8. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
9. MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
10. Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
11. IPC The Hospitalist Companys Philip Vaidyan, M.D. Named a Top Hospitalist of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Treato ... on healthcare, announced today that it has been named ... Cool Vendor in Life Sciences, 2016, Stephen ...  The report focuses on life-science- oriented analytics, algorithms and ... patients and doctors, confirm medication ingestion, and analyze unstructured ...
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
Breaking Medicine Technology:
(Date:4/29/2016)... , ... April 29, 2016 , ... ... of a growth round of funding led by Eastside Partners, with participation from ... company’s rapidly growing customer base and accelerate its technology and product roadmap. ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... to promote their animal line of probiotics, Petbiotics ™, as they fondly ... turnout of animal rescue groups networking for their non-profit organizations. Animal rescues across ...
(Date:4/29/2016)... ... 29, 2016 , ... Coalition Duchenne, a Newport Beach, California ... Duchenne research, participated in the April 25 U.S. Food and Drug Administration advisory ... The meeting at the Marriott Conference Center in Hyattsville, Maryland was attended by ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... data for 2014. Each year, reproductive endocrinologists are required to report in ... main organization of professionals dedicated to the practice of assisted reproductive technologies in ...
Breaking Medicine News(10 mins):